Abstract:Background and Purpose - Human brain arteriovenous malformation tissue displays increased levels of vascular endothelial growth factor (VEGF) as well as matrix metalloproteinase (MMP)- 9, a tissue protease associated with various intracerebral hemorrhage (ICH). We hypothesized that increased MMP- 9 was associated with ICH induced by vascular endothelial growth factor hyperstimulation and that this effect could be attenuated by nonspecific MMP inhibition.Methods - We used a mouse model with adenoviral vector- mediated vascular endothelial growth factor transduction in the brain. The association of MMP- 9 expression and the brain tissue hemoglobin levels, an index of ICH, after stereotactic injection of adenoviral vector- mediated vascular endothelial growth factor into caudate putamen was assessed. A dose - response study with adenoviral vector- mediated vascular endothelial growth factor and a time course study at both 24 and 48 hours postinjection were performed. Effects of minocycline, a nonspecific MMP inhibitor, and pyrrolidine dithiocarbamate, an upstream regulator of MMPs, on MMP- 9 activity and thereby the degree of ICH were also tested.Results - Adenoviral vector- mediated vascular endothelial growth factor at the higher dose and at 48 hours induced MMP- 9 levels 6- fold (n = 6, P = 0.02) and increased brain tissue hemoglobin (43.4 +/- 11.5 versus 30.3 +/- 4.1 mu g/mg, n = 6, P = 0.003) compared with the adenoviral vector control. Immnunostaining was positive for MMP- 9 around the cerebral vessels and the hemorrhagic areas. Minocycline and pyrrolidine dithiocarbamate administration suppressed vascular endothelial growth factor- induced MMP- 9 activity (n = 6, P = 0.003 and P = 0.01, respectively) and the associated increases in hemoglobin levels (n = 5 - 6, P = 0.001 and P = 0.02, respectively).Conclusions - Vascular endothelial growth factor- induced ICH is associated with increased MMP- 9 expression. Suppression of MMP- 9 by minocycline or pyrrolidine dithiocarbamate attenuated ICH, suggesting the therapeutic potential of MMP inhibitors in cerebral vascular rupture.

Hypoxia-controlled matrix metalloproteinase-9 hyperexpression promotes behavioral recovery after ischemia

Hypoxia Response Element-Regulated MMP-9 Promotes Neurological Recovery Via Glial Scar Degradation and Angiogenesis in Delayed Stroke

Lentivirus-Mediated Transfer Of Mmp-9 Shrna Provides Neuroprotection Following Focal Ischemic Brain Injury In Rats

Ischemic Postconditioning Diminishes Matrix Metalloproteinase 9 Expression and Attenuates Loss of the Extracellular Matrix Proteins in Rats Following Middle Cerebral Artery Occlusion and Reperfusion

Matrix Metalloproteinase-9 Expression is Enhanced by Ischemia and Tissue Plasminogen Activator and Induces Hemorrhage, Disability and Mortality in Experimental Stroke

Mmp-9, a Potential Target for Cerebral Ischemic Treatment.

Activation of Cerebral Recovery by Matrix Metalloproteinase-9 after Intracerebral Hemorrhage

Early inhibition of MMP activity in ischemic rat brain promotes expression of tight junction proteins and angiogenesis during recovery.

Hypoxia Inducible Factor-1α Attenuates Ischemic Brain Damage by Modulating Inflammatory Response and Glial Activity.

Study of matrix metalloproteinase 9 expression after mice ischemia/reperfusion in hippocampus and treatment effects of Yangyin Tongnao granule(养阴通脑颗粒)

Therapeutic Application of Gene Silencing Mmp-9 in A Middle Cerebral Artery Occlusion-Induced Focal Ischemia Rat Model

Matrix Metalloproteinase-9 and Ischemic Cerebrovascular Diseases

Adeno-Associated Viral Vector-Mediated Hypoxia-Inducible Vascular Endothelial Growth Factor Gene Expression Attenuates Ischemic Brain Injury after Focal Cerebral Ischemia in Mice

Matrix Metalloproteinase-9 Inhibition Attenuates Vascular Endothelial Growth Factor-Induced Intracerebral Hemorrhage

The Change of Matrix Metalloproteinase-9 Early Expression after Cerebral Ischemia-Reperfusion Injury

Expression of MMP-9 after Focal Cerebral Ischemia and Reperfusion in Rats

Inhibition of HIF-1α Reduced Blood Brain Barrier Damage by Regulating MMP-2 and VEGF During Acute Cerebral Ischemia.

Abstract WP298: Matrix Metalloproteinases Are Involved in the Regulation of Angiogenesis after Intracerebral Hemorrhage

Abstract 2058: Expression of Brain MMP9 in a Rat Model of Cardiopulmonary Resuscitation Treated with SB-3CT

Matrix Metalloproteinase-9 Contributes to Epilepsy Development after Ischemic Stroke in Mice

A Therapeutic Target Of Cerebral Hemorrhagic Stroke: Matrix Metallo-Proteinase-9